Arch Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arch Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 384% to $75,724. Profit margin reached -9221%. Total operating expenses were $5,042,044.

Profit Margin

Arch Therapeutics, Inc. (OTC:ARTH): Profit margin
2014 0 -8.14M
2015 0 -2.94M
2016 0 -5.99M
2017 0 -7.78M
2018 0 -4.81M
2019 0 -2.72M
2020 0 -4.01M
2021 11.56K -6.56M -56802.78%
2022 15.65K -4.27M -27318.26%
2023 75.72K -6.98M -9221.43%

ARTH Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
75.72K15.65K11.56K0000000
Cost of revenue
78.16K51.48K26.28K6.92K8.23K01.49K000
Gross profit
-2.43K-35.83K-14.71K-6.92K-8.23K0-1.49K000
Operating exp.
Research and development
670.88K1.15M1.35M1.61M2.39M2.88M2.09M1.68M1.76M1.47M
Selling and marketing
0000000000
Total operating expenses
5.04M5.67M6.36M5.37M6.37M7.44M7.30M6.05M5.46M4.61M
Operating income
-5.04M-5.70M-6.37M-5.37M-6.37M-7.44M-7.30M-6.05M-5.46M-4.61M
Other income (expenses), net
-1.93M432.95K136.64K660.73K1.82M2.63M-486.30K335.09K2.51M-3.53M
Income before tax
-6.98M-5.27M-6.24M-4.69M-4.54M-4.81M-7.78M-5.99M-2.94M-8.14M
Income tax expense
0-1M328.76K-679.27K-1.82M2.63M52.38K0377.48K111.05K
Net income
-6.98M-4.27M-6.56M-4.01M-2.72M-4.81M-7.78M-5.99M-2.94M-8.14M
Earnings per share
Basic EPS
-2.27-3.56-5.97-4.27-3.27-6.3-10.91-9.87-7.24-24.13
Diluted EPS
-2.27-3.56-5.97-4.27-3.27-6.3-10.91-9.87-7.24-24.13
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source